Stockreport

FDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related Bleeding Due to Ticagrelor and Initiates Substantive Review

Cytosorbents Corporation  (CTSO) 
Last cytosorbents corporation earnings: 11/5 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: cytosorbents.com
PDF PRINCETON, N.J., Oct. 22, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive c [Read more]